ELOX — Eloxx Pharmaceuticals Share News
0.000.00%
Last trade - 00:00Eloxx Pharmaceuticals Inc expected to post a loss of 14 cents a share - Earnings Preview
Eloxx Pharmaceuticals Inc expected to post a loss of 14 cents a share - Earnings Preview
Eloxx Pharmaceuticals Inc expected to post a loss of 14 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Dare Bioscience, Aurora Mobile, Didi Global
Eloxx Pharma rises on progress update for cystic fibrosis therapy study
Brief: Eloxx Pharmaceuticals Provides Enrollment Update For Ongoing Phase 2 Clinical Studies For Cystic Fibrosis
U.S. RESEARCH ROUNDUP-Ceridian HCM Holding, Norwegian Cruise Line Holdings, Royal Caribbean Group
Eloxx Pharma rises as B Riley starts with 'buy', receives funding
U.S. STOCKS ON THE MOVE-Hyrecar, Plantronics, Walt Disney
U.S. STOCKS ON THE MOVE-Eloxx Pharma, Fisker, Monaker
U.S. STOCKS ON THE MOVE-Fisker, Disney, Bionano Genomics
Eloxx Pharma drops on deep-discounted stock offering
Eloxx Pharma plunges on stock offering
Brief: Eloxx Pharmaceuticals Announces Proposed Public Offering Of Common Stock
Eloxx Pharmaceuticals Inc expected to post a loss of 17 cents a share - Earnings Preview
Eloxx Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: Eloxx Pharmaceuticals Reports First Quarter 2021 Financial And Operating Results And Provides Business Update
Brief: Eloxx Pharmaceuticals Adds Additional Treatment Arm To Ongoing Phase 2 Clinical Studies For Cystic Fibrosis
NASDAQ RESUMED AT 08:15 AM